SEC Form 4 · accession 0001062993-15-003115
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Gitman
Director
Period of report
May 27, 2015
Accepted (ET)
May 28, 2015 · 3:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | May 27, 2015 | M | 24,000 | $4.00 | A | 90,825 | D | |
| Common Stock, $0.001 par valueF1 | May 27, 2015 | S | 24,000 | $42.00 | D | 66,825 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.00 | May 27, 2015 | M | 24,000 | D | Mar 2, 2007 | Mar 2, 2017 | Common Stock, $0.001 par value | 24,000 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014.